Surgical Innovations, the AIM-listed manufacturer of tools for minimally invasive surgery, has put in a strong second half with full-year profit expected to be in-line with expectations.
In a trading update for the year ended 31 December 2018, the med tech specialist said it expects full-year revenue to be £11 million. This represents a rise of around 25% on the previous year.
Underlying revenue growth, adjusted for the impact of the 2017 acquisition of Elemental Healthcare, is slated to be 8%.
The company continues to be cash generative with closing new cash balances of around £360,000 – compared with net debt of £730,000 at the start of the year.